170 related articles for article (PubMed ID: 36923474)
1. Clinical characteristics and outcome of elderly onset adult-onset Still's disease: A 10-year retrospective study.
Li S; Ying S; Bai J; Wang Y; Yang C; Sun Q; Fang H; Qiao J
J Transl Autoimmun; 2023; 6():100196. PubMed ID: 36923474
[TBL] [Abstract][Full Text] [Related]
2. Clinical Characteristics of Japanese Patients with Elderly-Onset Adult-Onset Still's Disease.
Suzuki E; Temmoku J; Fujita Y; Yashiro-Furuya M; Asano T; Kanno T; Migita K
Tohoku J Exp Med; 2021 Nov; 255(3):195-202. PubMed ID: 34759075
[TBL] [Abstract][Full Text] [Related]
3. Macrophage activation syndrome complicating adult onset Still's disease: A single center case series and comparison with literature.
Lenert A; Yao Q
Semin Arthritis Rheum; 2016 Jun; 45(6):711-6. PubMed ID: 26672682
[TBL] [Abstract][Full Text] [Related]
4. Clinical characteristics and treatment of elderly onset adult-onset Still's disease.
Kishida D; Ichikawa T; Takamatsu R; Nomura S; Matsuda M; Ishii W; Nagai T; Suzuki S; Ueno KI; Tachibana N; Shimojima Y; Sekijima Y
Sci Rep; 2022 Apr; 12(1):6787. PubMed ID: 35474094
[TBL] [Abstract][Full Text] [Related]
5. Macrophage activation syndrome associated with adult-onset Still's disease: a multicenter retrospective analysis.
Wang R; Li T; Ye S; Tan W; Zhao C; Li Y; de Bao C; Fu Q
Clin Rheumatol; 2020 Aug; 39(8):2379-2386. PubMed ID: 32130578
[TBL] [Abstract][Full Text] [Related]
6. Clinical features of elderly-onset Adult-onset Still's disease.
Maruyama A; Kokuzawa A; Yamauchi Y; Kirino Y; Nagai H; Inoue Y; Ota T; Chifu Y; Inokuchi S; Koarada S; Ohta A; Iwamoto M; Tada Y
Mod Rheumatol; 2021 Jul; 31(4):862-868. PubMed ID: 32990106
[TBL] [Abstract][Full Text] [Related]
7. Elderly-onset Still's Disease Complicated by Macrophage Activation Syndrome: A Case Report and Review of the Literature.
Suda T; Zoshima T; Takeji A; Suzuki Y; Mizushima I; Yamada K; Nakashima A; Yachie A; Kawano M
Intern Med; 2020 Mar; 59(5):721-728. PubMed ID: 31708548
[TBL] [Abstract][Full Text] [Related]
8. Epidemiological study of adult-onset Still's disease using a Japanese administrative database.
Sakata N; Shimizu S; Hirano F; Fushimi K
Rheumatol Int; 2016 Oct; 36(10):1399-405. PubMed ID: 27502500
[TBL] [Abstract][Full Text] [Related]
9. Response rate of initial conventional treatments, disease course, and related factors of patients with adult-onset Still's disease: Data from a large multicenter cohort.
Kalyoncu U; Solmaz D; Emmungil H; Yazici A; Kasifoglu T; Kimyon G; Balkarli A; Bes C; Ozmen M; Alibaz-Oner F; Erten S; Cagatay Y; Cetin GY; Yilmaz S; Yildiz F; Pamuk ON; Kucuksahin O; Kilic L; Yazisiz V; Karadag O; Koca SS; Hayran M; Akar S; Aksu K; Akkoc N; Keser G; Gonullu E; Kisacik B; Onat AM; Soy M; Inanc N; Direskeneli H; Sayarlioglu M; Erken E; Turgay M; Cefle A; Ertenli I; Pay S
J Autoimmun; 2016 May; 69():59-63. PubMed ID: 26970681
[TBL] [Abstract][Full Text] [Related]
10. Latent class analysis of 216 patients with adult-onset Still's disease.
Sugiyama T; Furuta S; Hiraguri M; Ikeda K; Inaba Y; Kagami SI; Kita Y; Kobayashi K; Kobayashi Y; Kurasawa K; Nakagomi D; Nawata Y; Kawasaki Y; Shiko Y; Sugiyama T; Nakajima H
Arthritis Res Ther; 2022 Jan; 24(1):7. PubMed ID: 34980244
[TBL] [Abstract][Full Text] [Related]
11. Risk of macrophage activation syndrome in patients with adult-onset Still's disease with skin involvement: A retrospective cohort study.
Ding Y; Tang S; Li S; Yang C; Liu T; Ying S; Zhu D; Sun C; Chen W; Shi Y; Fang H; Qiao J
J Am Acad Dermatol; 2021 Dec; 85(6):1503-1509. PubMed ID: 33556412
[TBL] [Abstract][Full Text] [Related]
12. A comprehensive review on adult onset Still's disease.
Giacomelli R; Ruscitti P; Shoenfeld Y
J Autoimmun; 2018 Sep; 93():24-36. PubMed ID: 30077425
[TBL] [Abstract][Full Text] [Related]
13. Interleukin 18: a biomarker for differential diagnosis between adult-onset Still's disease and sepsis.
Priori R; Colafrancesco S; Alessandri C; Minniti A; Perricone C; Iaiani G; Palazzo D; Valesini G
J Rheumatol; 2014 Jun; 41(6):1118-23. PubMed ID: 24786926
[TBL] [Abstract][Full Text] [Related]
14. Clinical characteristics of macrophage activation syndrome in adult-onset Still's disease.
Gao Q; Yuan Y; Wang Y; Jiang J; Ye Z; Liu T; Jiang Z; Zhao L
Clin Exp Rheumatol; 2021; 39 Suppl 132(5):59-66. PubMed ID: 34251315
[TBL] [Abstract][Full Text] [Related]
15. Evaluating the multivisceral involvement on adult-onset Still's disease to retrieve imaging-based differences in patients with and without macrophage activation syndrome: results from a single-centre observational study.
Di Cola I; Bruno F; Berardicurti O; Monti R; Conforti A; Di Sibio A; Pavlych V; Masciocchi C; Barile A; Cipriani P; Ruscitti P
Clin Rheumatol; 2021 Oct; 40(10):3971-3978. PubMed ID: 33855668
[TBL] [Abstract][Full Text] [Related]
16. Impact of smoking habit on adult-onset Still's disease prognosis, findings from a multicentre observational study.
Ruscitti P; Di Cola I; Berardicurti O; Conforti A; Iacono D; Pantano I; Rozza G; Rossi S; De Stefano L; Balduzzi S; Vitale A; Caso F; Costa L; Prete M; Navarini L; Atzeni F; Guggino G; Perosa F; Cantarini L; Frediani B; Montecucco C; Ciccia F; Giacomelli R; Cipriani P
Clin Rheumatol; 2022 Mar; 41(3):641-647. PubMed ID: 34636022
[TBL] [Abstract][Full Text] [Related]
17. Application of the international league against rheumatism classification criteria for systemic juvenile idiopathic arthritis as a prognostic factor in patients with adults-onset Still's disease.
Yang JW; Lee E; Seo JY; Jung JY; Suh CH; Kim HA
Pediatr Rheumatol Online J; 2018 Jan; 16(1):9. PubMed ID: 29370863
[TBL] [Abstract][Full Text] [Related]
18. Response to Interleukin-1 Inhibitors in 140 Italian Patients with Adult-Onset Still's Disease: A Multicentre Retrospective Observational Study.
Colafrancesco S; Priori R; Valesini G; Argolini L; Baldissera E; Bartoloni E; Cammelli D; Canestrari G; Cantarini L; Cavallaro E; Cavalli G; Cerrito L; Cipriani P; Dagna L; Marchi G; Vita S; Emmi G; Ferraccioli G; Frassi M; Galeazzi M; Gerli R; Giacomelli R; Gremese E; Iannone F; Lapadula G; Lopalco G; Manna R; Mathieu A; Montecucco C; Mosca M; Piazza I; Piga M; Pontikaki I; Romano M; Rossi S; Rossini M; Ruscitti P; Silvestri E; Stagnaro C; Talarico R; Tincani A; Viapiana O; Vitiello G; Fabris F; Bindoli S; Punzi L; Galozzi P; Sfriso P
Front Pharmacol; 2017; 8():369. PubMed ID: 28659802
[No Abstract] [Full Text] [Related]
19. Usefulness of Interleukin-18 as a Diagnostic Biomarker to Differentiate Adult-Onset Still's Disease With/Without Macrophage Activation Syndrome From Other Secondary Hemophagocytic Lymphohistiocytosis in Adults.
Shiga T; Nozaki Y; Tomita D; Kishimoto K; Hirooka Y; Kinoshita K; Funauchi M; Matsumura I
Front Immunol; 2021; 12():750114. PubMed ID: 34691064
[TBL] [Abstract][Full Text] [Related]
20. Association of intercellular adhesion molecule-1 with clinical manifestations and interleukin-18 in patients with active, untreated adult-onset Still's disease.
Chen DY; Lan JL; Lin FJ; Hsieh TY
Arthritis Rheum; 2005 Jun; 53(3):320-7. PubMed ID: 15934126
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
